 BEDFORD, Mass.--BUSINESS WIRE--Stoke Therapeutics, Inc. Nasdaq: STOK, a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today announced that management will present at two upcoming investor conferences in November. Credit Suisse 30th Annual Healthcare Conference Date: Wednesday, November 10, 2021 Time: 10:30 a.m. ET Stifel 2021 Virtual Healthcare Conference Date: Monday, November 15, 2021 Time 